Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Change Your Physical make-up: Compelling Activities for Muscle Building - 2Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer
- 3Productive CRM Programming for Client Relationship The executives
- 4Investigating Design and Individual Style: Track down Your Remarkable Look
- 5KJ Apa stars as Jimmy Stewart in new biopic: See his transformation
- Lucrative Positions in the Advancing Position Market of 2024
- The most effective method to Keep up with Proficient Handshakes in a Computerized World
- Brazil's former President Jair Bolsonaro seeks house arrest for prison time citing health issues
- Wegmans recalls mixed nuts over salmonella contamination fears
- What to know about King Charles III's cancer treatment and his message to the public
- Scientists discover black hole flare with the light of 10 trillion suns
- Science is best communicated through identity and culture – how researchers are ensuring STEM serves their communities
- The Best 15 Applications for Efficiency and Association
- The risk of falling space junk hitting airplanes is on the rise, experts warn
